Document is current
Any future updates will be listed below
-
Authors
Raeisi Dehkordi, Siavash
Wong, Ivy Tsz-Lo https://orcid.org/0000-0002-9761-3422
Ni, Jing
Luebeck, Jens https://orcid.org/0000-0003-4391-979X
Zhu, Kaiyuan https://orcid.org/0000-0001-9976-6505
Prasad, Gino https://orcid.org/0000-0003-4590-1278
Krockenberger, Lena https://orcid.org/0009-0002-5987-5496
Xu, Guanghui https://orcid.org/0000-0001-7986-7077
Chowdhury, Biswanath
Rajkumar, Utkrisht
Caplin, Ann
Muliaditan, Daniel https://orcid.org/0000-0001-7277-9744
Gnanasekar, Aditi
Coruh, Ceyda
Jin, Qiushi
Turner, Kristen
Teo, Shu Xian
Pang, Andy Wing Chun https://orcid.org/0000-0002-0558-3802
Alexandrov, Ludmil B. https://orcid.org/0000-0003-3596-4515
Chua, Christelle En Lin
Furnari, Frank B. https://orcid.org/0000-0003-1909-4361
Maciejowski, John https://orcid.org/0000-0001-8134-9308
Paulson, Thomas G. https://orcid.org/0000-0002-3857-2683
Law, Julie A. https://orcid.org/0000-0001-7472-7753
Chang, Howard Y. https://orcid.org/0000-0002-9459-4393
Yue, Feng https://orcid.org/0000-0002-7954-5462
DasGupta, Ramanuj https://orcid.org/0000-0001-9015-3729
Zhao, Jean https://orcid.org/0000-0002-4561-5688
Mischel, Paul S. https://orcid.org/0000-0002-4560-2211
Bafna, Vineet https://orcid.org/0000-0002-5810-6241
-
Funding
Funding for this research was provided by:
Cancer Research UK (CGCATF-2021/100025)
- License Information
-
More Information
Article History
Received: 27 September 2024
Accepted: 24 January 2025
First Online: 10 February 2025
Competing interests
: V.B. is a co-founder, consultant, SAB member and has equity interest in Boundless Bio and Abterra, and the terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. P.S.M. is a co-founder, chairs the scientific advisory board (SAB) of and has equity interest in Boundless Bio. P.S.M. is also an advisor with equity for Asteroid Therapeutics and is an advisor to Sage Therapeutics. H.Y.C. is a co-founder of Accent Therapeutics, Boundless Bio, Cartography Bio, and Orbital Therapeutics, and is an advisor to 10X Genomics, Arsenal Biosciences, Chroma Medicine, and Spring Discovery. J.J.Z. is co-founder and director of Crimson Biopharm Inc. and Geode Therapeutics Inc. LBA is a co-founder, CSO, scientific advisory member, and consultant for io9, has equity and receives income. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. LBA is a compensated member of the scientific advisory board of Inocras. LBA’s spouse is an employee of Hologic, Inc. LBA declares U.S. provisional applications with serial numbers: 63/289,601; 63/269,033; 63/366,392; 63/412,835 as well as international patent application PCT/US2023/010679. LBA is also an inventor of a US Patent 10,776,718 for source identification by non-negative matrix factorization. K.H. is a former employee of Boundless Bio, Inc. The remaining authors declare no competing interests.
